Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can numbing cream boost recovery after spinal injury?

NCT ID NCT05589402

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This early study tests a simple idea: temporarily numbing non-paralyzed arm muscles with an over-the-counter lidocaine cream while exercising paralyzed muscles. Researchers hope this will improve strength, function, and sensation in people with spinal cord injury. About 30 adults with chronic incomplete spinal cord injury will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lidocaine cream 5% (numbing cream) plus rehabilitation movement training
What this could lead to
If it works, this could point toward a simple, low-cost way to make rehab more effective for people with spinal cord injury.
What could go wrong
This is a very early Phase 1 trial with only 30 participants, so results may not be conclusive. The numbing cream is temporary and may not produce lasting improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

52 people

The number who actually took part.

Started

Jun 2019

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: SCI Patients: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, aged between 18 and 75 years old * Have physician diagnosed cervical incomplete spinal cord injury or lesion (iSCI) * Classified by the American Spinal Cord Association (AIS) impairment scale as AIS C or D * iSCI occurred at least 18 months ago * Level of injury or lesion is between C2 and T1 * Bicep strength must be classified as ≥ 3 muscle grade as defined by the medical research council scale * Tricep strength must be at least an MRC grade of 2 and bet at least 1 muscle grade lower than the bicep * Both the biceps and triceps will be required to elicit an active motor evoked potential \>200 uV with transcranial magnetic stimulation * Must maintain current medication regime * Must present with a weaker side of the body, as indicated by a Upper extremity motor score difference between the left and right side * UEMS \< 40 (50 max score) * Must be able to perform reaching movement training task Healthy Controls: * Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, aged between 18 and 75 years old * Must be right-handed * Must be able to perform hand exercises Exclusion Criteria: SCI Patients: * Pacemaker or another implanted device * Metal in the skull * History of seizures * Pregnancy * First-degree relative with medication-resistant epilepsy * Current participation in upper limb rehabilitation therapies * Current use of illicit drugs, abusing alcohol, or have withdrawn from alcohol in the last 6 months * Other neurological impairment or condition * Pressure ulcers * Significant lower motor neuron loss at C7 as noted by a nerve conduction velocity \<50 m/s * History of traumatic brain injury as documented by Rancho Scale Impairment of \<5 * History of brain MRI documented focal cerebral cortex infarct (e.g. hydrocephalus) * Contractures at the elbow * Severe spasticity as noted by a modified ashworth scale (MAS) \> 4 * Documented, non-sedated post-traumatic amnesia lasting more than 48 hours * Pregnancy * Allergic to lidocaine * A neuroactive medication that has the potential to lower the seizure threshold * Based on documented publications in stroke, this will include bupropion (wellbutrin), psychostimulants and neuroleptics * All medications will be reviewed with physician, Dr. Amol Utturkar (DHR) Healthy Controls: * Pacemaker or other implanted device * Metal in the skull * History of seizures * First-degree relative with medication-resistant epilepsy * Current use of illicit drugs (including heroin, crack/cocaine, marijuana), abusing alcohol or having withdrawn from alcohol in the last 6 months * Allergy to lidocaine * Other neurological impairment or condition * Pregnancy * A neuroactive medication that has the potential to lower the seizure threshold * Based on documented publications on stroke, this will include bupropion (wellbutrin), psychostimulants and neuroleptics

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Texas Rio Grande Valley

    Harlingen, Texas, 78550, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.